Analgesics in Bosnia and Herzegovina remains highly saturated in 2024, facing increasing pressures from a demographic crisis and ongoing political instability. Despite these challenges, the category is witnessing moderate retail volume growth. Rising inflation and escalating product prices have played a crucial role in driving solid retail sales price value growth, compensating for the relatively flat consumer base. In 2024, topical analgesics have outperformed systemic alternatives, a shift dri...
Euromonitor International's Analgesics in Bosnia and Herzegovina report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. Forecasts to 2028 illustrate how the market is set to change.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report? * Get a detailed picture of the Analgesics market; * Pinpoint growth sectors and identify factors driving change; * Understand the competitive environment, the market’s major players and leading brands; * Use five-year forecasts to assess how the market is predicted to develop.
Analgesics in Bosnia and Herzegovina
Euromonitor International
September 2024
List Of Contents And Tables
ANALGESICS IN BOSNIA AND HERZEGOVINA
KEY DATA FINDINGS
2024 DEVELOPMENTS
Saturation and moderate growth amid demographic challenges
Increased interest in paediatric ibuprofen despite controversy
Non-steroidal anti-inflammatory drugs (NSAIDs) gain traction